Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment.
about
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice GuidelineExpression of melanocortin receptors in human endometrium.Spontaneous and tetracosactide-induced anti-ACTH antibodies in man.A review of the re-emergence of adrenocorticotrophic hormone therapy in glomerular disease, more than a drug of last resort?High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients.Isolation of a multipotent mesenchymal stem cell-like population from human adrenal cortex.
P2860
Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Residual adrenal function in a ...... osactide (ACTH1-24) treatment.
@en
Residual adrenal function in a ...... provement after tetracosactide
@nl
type
label
Residual adrenal function in a ...... osactide (ACTH1-24) treatment.
@en
Residual adrenal function in a ...... provement after tetracosactide
@nl
prefLabel
Residual adrenal function in a ...... osactide (ACTH1-24) treatment.
@en
Residual adrenal function in a ...... provement after tetracosactide
@nl
P2093
P50
P356
P1476
Residual adrenal function in a ...... cosactide (ACTH1-24) treatment
@en
P2093
Beverly A Hughes
Jadwiga Furmaniak
Katie MacArthur
R Andrew James
Richard Quinton
Stephen G Ball
P304
P356
10.1210/JC.2013-2449
P407
P577
2013-12-20T00:00:00Z